Utilizing conventional techniques, the three surgeries likely would have been split between two or three different settings and required the patient to be moved between the neuro OR and diagnostic MRI suite. The ClearPoint system, however, enables placement of multiple devices along the same trajectory, as well as facilitates intraoperative adjustments with real-time visual verification to accommodate multiple trajectories as necessary, all within a hospital's standard diagnostic MRI scanner.
MRI Interventions Business Development Manager and clinical engineer
Using the ClearPoint system for the biopsy,
The ClearPoint system is the only technology to enable minimally-invasive neurosurgery under continuous MRI guidance. In addition to brain biopsy and the placement of shunts and laser ablation catheters, the ClearPoint system is also being utilized to place electrodes in the brain.
About the ClearPoint system
The ClearPoint system is a navigation platform designed to allow real-time, direct visualization during minimally-invasive neurosurgical procedures. It is intended to provide stereotactic guidance for the placement and operation of instruments or devices during planning and operation of neurosurgical procedures within the MRI environment and in conjunction with MR imaging. The ClearPoint system is intended as an integral part of procedures that have traditionally used stereotactic methodology, which procedures include biopsies and catheter and electrode insertions. The ClearPoint system software works with MRI to assist surgeons in planning a target and trajectory, and the SmartFrame® targeting device enables the MRI-guided alignment and insertion of surgical instruments.
Building on the imaging power of MRI, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. The company's ClearPoint® system, which has received 510(k) clearance and is CE marked, utilizes a hospital's existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. In partnership with
Certain matters in this press release may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements often can be identified by words such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "should," "will," "would," or the negative of these words or other words of similar meaning. Forward-looking statements by their nature address matters that, to different degrees, are uncertain and involve risk. Uncertainties and risks may cause MRI Interventions' actual results and the timing of events to differ materially from those expressed in or implied by MRI Interventions' forward-looking statements. Detailed information on factors that could affect MRI Interventions' actual results are described in MRI Interventions' filings with the
MRI Interventions, Inc. David Carlson, CFO, 901-522-9300